期刊文献+

EGF受体和IGF-1受体在人鼻咽癌组织中的表达及临床意义 被引量:6

Expression and Clinical Significance of EGF Receptor and IGF-1 Receptor in Nasopharyngeal Carcinoma
原文传递
导出
摘要 目的:研究表皮生长因子受体(EGFR)和胰岛素生长因子-1受体(IGF-1R)在人鼻咽癌(NPC)组织中的表达及临床意义。方法:应用免疫组织化学SP法检测NPC组织及鼻咽非肿瘤组织EGFR和IGF-1R蛋白以及用RT-PCR法检测EGFR和IGF-1R mRNA的表达。结果:EGFR和IGF-1R蛋白在NPC组织的过表达率分别为65.3%(49/75)和56%(42/75),在鼻咽非肿瘤组织中过表达率分别为0%和14.3%(3/21)。鼻咽癌组与对照组相比,EGFR蛋白表达有统计学意义(P<0.01),鼻咽癌组织中EGFR和IGF-1R蛋白的过表达对不同年龄、性别的患者无统计学差异,但与淋巴结转移、远处转移、复发和5年生存率有相关性(P<0.01或P<0.05)。鼻咽癌组与对照组相比,IGF-1R mRNA和EGFR mRNA表达亦有统计学差异(P<0.01或/P<0.05)。EGFR和IGF-1R两者在鼻咽癌中表达呈正相关(r=0.367,P=0.001)。结论:EGFR和IGF-1R mRNA和蛋白过度表达可能与鼻咽癌的复发和转移有关,检测EGFR和IGF-1R mRNA和蛋白过度表达可作为判断鼻咽癌复发和转移的潜在指标之一。 To investigate the expressions of EGF and IGF-1 receptors and their relation to the growth and apoptosis of nasopharyngeal carcinoma (NPC) and to explore the clinicopathologic significance. Methods: Seventy-five patients with NPC and twenty-one noncancerous nasopharyngeal epithelial samples were retrospectively studied from year 1997 to 2006, and the expressions of EGF and IGF-1 receptors were detected by immunohistochemical staining. Results. The levels of these two proteins significantly correlated with each other (correlation coefficience=0. 367, P =0. 001). And the overexpression rates of EGF and IGF-1 receptors were 65.3% and 56% in nasopharyngeal samples, respectively. Furthermore, both protein expressions were significantly higher in NPC patients with cervical lymph node or distant metastasis than in NPC patients without. Conehlsion.- These findings demonstrate that both receptor proteins may play important roles in the invasion, metastasis, and recurrence of NPC. Both receptors are valuable markers for assessing the prognosis of NPC.
出处 《武汉大学学报(医学版)》 CAS 北大核心 2009年第3期294-298,I0001,共6页 Medical Journal of Wuhan University
基金 湖北省自然科学基金资助项目(编号:301130717303130715)
关键词 鼻咽癌 EGF受体 IGF-1受体 免疫组织化学 RT-PCR EGF Receptor Immunohistochemistry Nasopharyngeal Carcinoma IGF-1 Re-ceptor RT-PCR
  • 相关文献

参考文献11

  • 1Lee Y, Imsumran M, Park S, et al. Adenovirus expressing shRNA to IGF-1R enhances the chemosensi tivty of lung cancer cell lines by blocking IGF-1 path way [J]. Lung Cancer,2007, 55(3) : 279-286.
  • 2Wu XB, Deng YZ, Wang GB, et al. Combining siRNAs at two different sites in the EGFR to suppress its expression, induce apoptosis, and enhance 5-fluorouracil sensitivity of colon cancer cells[J].Journal of Surgical Research, 2007,138(1):56-63.
  • 3傅江涛,赵碧芬,胡向荣,欧阳露.表皮生长因子受体在鼻咽癌中的表达及意义[J].中国耳鼻咽喉颅底外科杂志,2004,10(5):271-273. 被引量:9
  • 4Huether A, Hopfner M, Baradari V, et al. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer [J]. Biochem Pharmacol, 2005, 70(11):1 568-1 578.
  • 5陈翔,冉志华,林维,萧树东.胰岛素样生长因子的表达及其与结肠癌生物学行为的相关性[J].胃肠病学,2006,11(3):139-142. 被引量:2
  • 6Michael H, Alexander H, Andreas P, et al. Blockade of IGF-1 receptor tyrosine kinase has antineoplastie effects in hepatocellular carcinoma cells [J]. Bioch Pharmac, 2006 , 71:1 435-1 448.
  • 7Blum G, Gazit A, Levitzki A. Development of new insulin-like growth factor- 1 receptor kinase inhibitors using catechol mimics[J]. J Biological Chemistry, 2003,278:40 442-40 454.
  • 8Gimita A, Gimita L, Prete FD, et al. Cyclolignans as inhibitors of the insulin-like growth factor-Ⅰ receptor and malignant cell growth [J]. Cancer Res, 2004, 64:236-242.
  • 9Ulfarsson E, Karstrom A, Yin S, et al. Expression and growth dependency of the insulin-like growth factor- Ⅰ receptor (IGF-1R) in cranioptaaryngioma cell: a novel therapeutic approach[J].Clin Cancer Res, 2005, (13):4 674-4 680.
  • 10Yuan YL, Zhou XH, Jian S, et al. Dual silencing of type 1 insulin-like growth factor and epidermal growth factor receptors to induce apoptosis of nasopharyngeal cancer cells [J]. J Laryngol Otol, 2008,122(10):952- 960.

二级参考文献19

  • 1郑唯强,倪灿荣,龚志锦,李全华,詹洲.乳腺癌上皮生长因子受体的临床病理观察及预后意义[J].癌症,1995,14(1):19-20. 被引量:3
  • 2许良中,郑颂国,朱伟萍,张秦明.EGFR与C-erbB-2癌基因蛋白在甲状腺乳头状腺癌中的表达[J].实用癌症杂志,1995,10(2):102-104. 被引量:4
  • 3李彦锋,方玉华,李黔生,邓晓洪,江军.癌性及良性增生前列腺组织中表皮生长因子受体的研究[J].中华实验外科杂志,1997,14(1):30-30. 被引量:4
  • 4O'Dell SD,Day IN.Insulin-like growth factor Ⅱ (IGF-Ⅱ).Int J Biochem Cell Biol,1998,30:767~771.
  • 5Braulke T.Type-2 IGF receptor:a multi-ligand binding protein.Horm Metab Res,1999,31:242~246.
  • 6Guo YS,Jin GF,Townsend CM Jr,Zhang T,Sheng HM,Beauchamp RD,Thompson JC.Insulin-like growth factorⅡ expression in carcinoma in colon cell lines:implications for autocrine actions.J Am Coll Surg,1995,181:145~154.
  • 7Sekharam M,Nasir A,Kaiser HE,Coppola D.Insulinlike growth factor 1 receptor activates c-SRC and modifies transformation and motility of colon cancer in vitro.Anticancer Res,2003,23:1517~1524.
  • 8Sekharam M,Zhao H,Sun M,Fang Q,Zhang Q,Yuan Z,Dan HC,Boulware D,Cheng JQ,Coppola D.Insulin-like growth factor 1 receptor enhances invasion and induces resistance to apoptosis of colon cancer cells through the Akt/Bcl-x(L) pathway.Cancer Res,2003,63:7708~7716.
  • 9Zhang D,Samani AA,Brodt P.The role of the IGF-Ⅰreceptor in the regulation of matrix metalloproteinases,tumor invasion and metastasis.Horm Metab Res,2003,35:802~808.
  • 10马丁.肿瘤转移.见:曾益新主编.肿瘤学.第二版.北京:人民卫生出版社,2003.241~266.

共引文献9

同被引文献98

引证文献6

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部